Author

F. Rinaldi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2 Immunology· 1 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. Cavalli· 2 shared R. Marotta· 2 shared S. GIROTTO· 2 shared A. Armirotti· 1 shared A. Gennari· 1 shared A. Lanna· 1 shared B. Balboni· 1 shared C. D'Ambra· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

A. Cavalli

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Disruptors of sestrin-MAPK interactions rejuvenate T cells and expand TCR specificity

A. Lanna, C. D'Ambra, F. Rinaldi, L. Chocarro De Erauso, M. Delpero, M. Capitani, M. Karin

This paper develops DOS, a first-in-class disruptor of sestrin-MAPK complexes, which rejuvenates senescent T cells and expands TCR specificity by generating new T cell clones.

bioRxiv · May 17, 2024 · PreprintImmunology

Novel structural insights on full-length human RAD52: Cryo-EM and beyond

B. Balboni, R. Marotta, F. Rinaldi, S. GIROTTO, A. Cavalli

This paper presents the Cryo-EM structure of full-length human RAD52 at 2.16 Å resolution, revealing its undecameric N-terminal ring and disordered C-terminal region, with implications for inhibitor development.

bioRxiv · Apr 3, 2023 · PreprintBiophysics

RAD51 nuclear recruitment and inhibition towards innovative strategies against pancreatic cancer

F. Schipani, M. Manerba, R. Marotta, A. Gennari, F. Rinaldi, A. Armirotti, M. Roberti, G. Di Stefano, W. Rocchia, N. Tirelli, S. Girotto, A. Cavalli

This study investigates BRC4's role in inhibiting RAD51's nuclear recruitment and its effect on HR in pancreatic cancer cells, showing enhanced cisplatin cytotoxicity.

bioRxiv · Feb 3, 2021 · PreprintBiophysics

Revisiting the decay of scientific email addresses

R. Rodriguez-Esteban, D. Vishnyakova, F. Rinaldi

The paper estimates that 18% of scientific email addresses in MEDLINE are invalid, lower than previous estimates, and suggests solutions like email forwarding and stable addresses.

bioRxiv · May 12, 2019Scientific Communication & Education